Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer

S R D Johnston, T Hickish, P Ellis, S Houston, L Kelland, M Dowsett, J Salter, B Michiels, J J Perez-Ruixo, P Palmer, A Howes

Research output: Contribution to journalArticlepeer-review

174 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology